Abstract
A variety of drugs may cause thrombocytopenia. Although it occurs more often than drug-induced anemia it is less well understood because techniques for studying drug-platelet-immune interactions have been unavailable until recently. The mechanisms by which drugs cause thrombocytopenia are varied. Bone marrow suppression or increased peripheral destruction of platelets could be involved. Nonimmunologic as well as immunologic mechanisms may also occur. These different mechanisms of drug-induced thrombocytopenia are reveiwed. Diagnostic methods and treatment are also summarized.
Similar content being viewed by others
References
Ackroyd, J.F., 1945. The mechanism of the reduction of clot retraction by sedromid in the blood of patients who have recovered from sedromid purpura. Clin. Sci., 8: 235.
Ackroyd, J.F., 1949a. The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedromid (allyl-isopropyl acetyl-carbamide). Clin. Sci., 7: 249.
Ackroyd, J.F., 1949b. The cause of thrombocytopenia in sedromid purpura. Clin. Sci., 8: 269.
Ackroyd, J.F., 1953. Seminars in blood coagulation. Allergic purpura, including purpura due to foods, drugs and infections. Am. J. Med., 14: 605.
Ackroyd, J.F., 1962. The immunological basis of purpura due to drug hypersensitivity. Proc. Roy. Soc. Med., 55: 30.
Ahn, Y.S., Harrington, W.J., Seelman, R.C. and Eytel, S.C., 1974. Vincristine therapy of idiopathic and secondary thrombocytopenias. N. Engl. J. Med., 291: 375.
Alving, B.M., Shuman, N.R., Bell, W.R., Evatt, B.L. and Tack, K.M., 1977. In vitro studies of heparin associated thrombocytopenia. Thromb. Res., 11: 827.
Ansell, J., Slepchuk, N., Kumar, R., Lopez, A., Southard, L. and Deykin, D., 1980. Heparin induced thrombocytopenia: A perspective study. Thromb. Haemost., 43: 61.
Appelbaum, F.R. and Fefer, A., 1981. The pathogenesis of aplastic anemia. Semin. Hematol., 18: 241.
Babcock, R.B., Dumper, C.W. and Scharfman, W.B., 1976. Heparin induced immune thrombocytopenia. N. Engl. J. Med., 295: 237.
Barr, R.D., Copeland, S.A., Moore, J.C., Stockwell, M.L., Morris, N. and Kelton, J.G., 1981. Valproic acid and immune thrombocytopenia. Blood, 58: 661A.
Beckett, A.G. and Foxell, A.W.H., 1955. Thrombocytopenia associated with oxytetracycline therapy. Lancet, 1: 1053.
Bell, W.R. and Royall, R.M., 1980. Heparin associated thrombocytopenia: A comparison of three heparin preparations. N. Engl. J. Med., 303: 902.
Berger, H., 1952. Thrombocytopenic purpura following use of digitoxin. J. Am. Med. Assn., 148: 2852.
Bessman, J.D., 1982. Prediction of platelet production during chemotherapy for acute leukemia. Am. J. Hematol., 13: 219.
Boggs, D.R. and Boggs, S.S., 1976. The pathogenesis of aplastic anemia: A defective pleuripotent hematopoietic stem cell with inappropriate balance of differentiation and self-replication. Blood, 48: 71.
Bolton, F.G. and Dameshek, W., 1956. Thrombocytopenic purpura due to quinine. Clinical studies. Blood, 11: 527.
Brooks, A.P., 1974. Thrombocytopenia during treatment with ampicillin. Lancet, 2: 723.
Capel-Edwards, K., Hall, D.E., Sansom, A.G., 1971. Hematological changes observed in female beagle dogs given ethynylestradiol. Toxic. Appl. Pharmac., 20: 319.
Castrodale, D., Bierbaum, O., Helwig, E.B. and MacBride, C.M., 1941. Comparative studies of the effects of estradiol and stilbestrol upon the blood, liver and bone marrow. Endocrinol., 29: 363.
Chiu, T., 1974. Studies on estrogen induced proliferative disorders of hematopoietic tissue in dogs. Dissert. Abs. Intnl., 35B: 3104.
Chong, B.H., Pitney, W.R. and Castaldi, P.A., 1982. Heparin-induced thrombocytopenia: Association of thrombotic complications with heparin dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet, 2: 1246.
Christie, D.J., Kunicki, T.J. and Aster, R.H., 1981. Characterization of the binding of quininine-dependent antibodies with human platelets by an electroimmunoassay (Abst). Transfusion, 21: 640.
Cines, D.B., Keywin, P., Bina, M., Tomaski, A. and Schreiber, A.D., 1980. Heparin-associated thrombocytopenia. N. Engl. J. Med., 303: 788.
Class, F.H., Van der Meer, J.W.M. and Langerak, J., 1979. Immunological effect of co-trimoxazole on platelets. Br. Med. J., 2: 898.
Cohen, P. and Gardner, F.H., 1961. The thrombocytopenic effect of sustained high dosage prednisone therapy in thrombocytopenic purpura. N. Engl. J. Med., 265: 611.
Conrad, M.E. and Carpenter, J.T., 1979. Bone marrow necrosis. Am. J. Hematol., 7: 181.
Cooper, B.A. and Bigelow, F.S., 1960. Thrombocytopenia associated with the administration of diethylstilbestrol in man. Ann. Intern. Med., 52: 907.
Copley, A.L. and Robb, T.P., 1942. Studies on platelets. III. The effect of heparin in vivo on platelet count of mice and dogs. Am. J. Clin. Pathol. 12: 563.
Crafts, R.C., 1948. The effects of estrogen on the bone marrow of adult female dogs. Blood, 3: 276.
Crandall, T.L., Joyce, R.A. and Boggs, D.R., 1980. Estrogens and hematopoiesis: Characterization and studies oin the mechanism of neutropenia. J. Lab. Clin. Med., 95: 857.
Cunningham, J.L., Leyland, M.J. and Delamore, I.W., 1974. Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia. Br. Med. J., 3: 313.
Darcie, J.V. and Worlledge, S.M., 1969. Autoimmune hemolytic anemias. In: E.R. Brown and C.V. Moore (Editors), Progress in Hematology, Vol. VI, Grune and Stratton, New York, p. 82.
Davey, M.G. and Lander, H., 1968. Effect of injected heparin on platelet levels in man. J. Clin. Pathol., 21: 55.
Deren, B., Masi, R., Weksler, M. and Nachman, R.L., 1974. Gold-associated thrombocytopenia. Arch. Intern. Med., 134: 1012.
Duncan, S.G., Meyers, K.M. and Reed, S.M., 1983. Reduction of the red blood cell mass of horse: Toxic effect of heparin anticoagulant therapy. Am. J. Vet. Res., 44: 2272.
Eisner, E.V. and Crowell, E.B., 1971. Hydrochlorthiazide-dependent thrombocytopenia due to IgM antibody. J. Am. Med. Assn., 215: 480.
Eisner, E.V., LaBocki, N.L. and Pickney, L., 1975. Chlorphenaramine-dependent thrombocytopenia. J. Am. Med. Assn., 231: 735.
Eisner, E.V. and Shahidi, N.T., 1972. Immune thrombocytopenia due to a drug metabolite. N. Engl. J. Med., 287: 376.
Fadok, V.A. and Janney, E.H., 1982. Thrombocytopenia and hemorrhage associated with gold salt therapy for bullous pemphigoid in a dog. J. Am. Vet. Med. Assoc. 181:261.
Feigin, E.D., Zarkowsky, H.F., Shearer, W. and Anderson, D.C., 1973. Thrombocytopenia following administration of para-aminosalicylic acid. J. Pediatr., 83: 502, 1973.
Fratantoni, J.C., Pollet, R. and Gralnick, H.R., 1975. Heparin-induced thrombocytopenia: Confirmation of diagnosis with in vitro methods. Blood, 45: 395.
Freedman, A.L., Brody, E.A. and Barr, P.S., 1956. Immunothrombocytopenic purpura due to quinidine: Report of 4 new cases with special observations on path testing. J. Lab. Clin. Med., 48: 205.
Gangarosa, E.J., Johnson, T.R. and Ramos, H.S., 1960. Ristocetin-induced thrombocytopenia: Site and mechanisms of action. Arch. Intern. Med., 105: 83.
Garg, S.K. and Sarker, C.R., 1974. Aspirin-induced thrombocytopenia on an immune basis. Am. J. Med. Sci. 267: 129.
Gesink, M.H. and Bradford, H.A., 1960. Thrombocytopenic purpura associated with hydrochlorothiazide therapy. J. Am. Vet. Med. Assn. 172: 556.
Gralnick, H.R., McGinniss, M. and Halterman, R., 1972. Thrombocytopenia with sodium cephalothin therapy. Ann. Intern. Med., 77: 401.
Hackett, T., Kelton, J.G. and Powers, P., 1982. Drug-induced platelet destruction. Semin. Thromb. Hemost. 8: 116.
Hagen, M.D. and White, R.D., 1983. Thrombocytopenia secondary to trimethoprin-sulfamethoxazole. South. Med. J., 76: 503.
Hamilton, H.E. and Sheets, R.F., 1978. Sulfisoxasole-induced thrombocytopenic purpura, immunologic mechanism as cause. J. Am. Med. Assn., 239: 2586.
Hartfall, S.J., Garland, H.G. and Goldie, W., 1937. Gold treatment of arthritis. Lancet, 2: 784.
Heyns, A. dup., Lotter, M.G., Badenhorst, P.N., Kotze, H., Killian, F.C., Herbst, C., van Reiner, O.R. and Minnaar, P.C., 1980. Kinetics and in vivo redistribution of 111 indium-labelled human platelets after intravenous protamine sulphate. Thromb. Haemost., 44: 65.
Hosseinzadeh, P.K., Firkin, B.G. and Pfueller, S.L., 1980. Study of factors that cause specific transformation in culture of lymphocytes from patients with quinine and quinidine induced thrombocytopenia. J. Clin. Invest., 66: 638.
Hurd, R.W. and Jacox, R.F., 1943. Thrombocytopenic purpura developing as a complication of sulfathiazole and sulfadizine therapy. J. Am. Med. Assn., 122: 296.
Karnofsky, D.A., 1968. Cancer chemotherapeutic agents. Cancer, 18: 80.
Kelton, J.G., Meltzer, D., Moore, J., Giles, A.R., Wilson, W.E., Barr, R., Hirsh, J., Neame, P.B., Powers, P.J., Walker, I., Bianchi, F. and Carter, C.J. 1981. Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood, 58: 524.
Kunicki, T.J., Johnson, M.M. and Aster, R.H. Absence of the platelet receptor for drug dependent antibodies in the Bernard Soulier syndrome. J. Clin. Invest., 62: 716.
Kutti, J. and Weinfeld, A., 1968. The frequence of thrombocytopenia in patients with heart disease treated with oral diuretics. Acta. Med. Scand., 183: 245.
Levin, H.A., McMillan, R., Tavassoli, M., Longmire, R.L., Yelenosky, R. and Sacks, P.V., 1975. Thrombocytopenia associated with gold therapy: Observations on the mechanism of platelet destruction. Am. J. Med., 59: 274.
LoBuglio, A.F. and Jandl, J.H., 1967. The nature of the alpha methyl dopa red-cell antibody. N. Engl. J. Med., 276: 658.
Magnusson, B. and Rodjer, S., 1980. Alprenolol-induced thrombocytopenia. Acta. Med. Scand. 207: 231.
Manohitharajah, S.M., Jenkins, W.J., Roberts, P.D., and Clarke, R.C., 1971. Methyldopa and associated thrombocytopenia. Br. Med. J., 1: 494.
Marcus, G.J., Stevenson, M. and Brown, T., 1975. Alpha methyl dopa induced immune thrombocytopenia: Report of a case. Am. J. Clin. Pathol. 64: 113.
Mettier, S.R., McBride, A. and Li, J., 1948. Thrombocytopenic purpura complicating gold therapy for rheumatoid arthritis. Blood, 3: 1105.
Morris, N., Barr, R.D., Pai, K.R.M. and Kelton, J.G., 1981. Valproic acid and thrombocytopenia. Can. Med. Assoc. J., 125: 63.
Murphy, M.F., Riordan, T., Minchinton, R.M., Chapman, J.F., Aness, J.A.L., Shaw, E.J. and Waters, A.H., 1983. Demonstration of an immune mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. Br. J. Haematol. 55: 155.
Nagao, T. and Maur, A.M., 1969. Concordance for drug-induced aplastic anemia in identical twins. N. Engl. J. Med., 275: 94.
Nicol, T. and Bilbey, D.L.J., 1960. The effect of various steroids on the phagocytic activity of the reticuloendothelial system. In: J.H. Heller (Editor), Reticuloendothial Structure and Function, Ronald, New York, p. 301.
Neiweg, H.O., Bonma, H.G.D., DeVries, K. and Jansz, A., 1963. Haematological side-effects of some anti-rheumatic drugs. Am. Rheum. Dis., 22: 440.
Pfueller, S.L., Hosseinzadeh, P.K. and Firkin, B., 1981. Quinin and quinidine dependent antiplatelet antibodies. J. Clin. Invest. 67: 907.
Pisciotta, A.V., 1973. Immune mechanisms in drug-induced agranulocytosis. Seminars in Hematology, 10: 273.
Price, A.E. and Leichteustritt, B., 1943. Gold therapy in rheumatoid arthritis. Ann. Intern. Med., 19: 70.
Pullen, J., 1981. Drug-induced thrombocytopenia. In: J.M. Lusher and M.I. Barnhart (Editors), Acquired Bleeding Disorders in Children, Mason, New York, p. 49.
Rachmilewitz, E.A., Dawson, R.B. Jr. and Rachmilewitz, B., 1968. Serum antibodies against desipramine as a possible cause for thrombocytopenia. Blood, 32: 524.
Rhodes, G.R., Dixon, R.H. and Silver, D., 1977. Heparin induced thrombocytopenia: Eight cases with thrombotic-hemorrhagic complications. Ann. Surg., 186: 752.
Robertson, J.H. and McCarthy, G.M., 1969. Periwinkle alkaloids and the platelet count. Lancet, 2: 353.
Rodriguez, S.U., Leikin, S. and Hiller, M.C., 1964. Neonatal thrombocytopenia associated with antepartum administration of thiazide drugs. N. Engl. J. Med., 270: 881.
Rosenthal, N., 1928. The blood picture in purpura. J. Lab. Clin. Med., 13: 303.
Rowsell, H.C., Glynn, M.F., Mustard, J.F. and Murphy, E.A., 1967. Effect of heparin on platelet economy in dogs. Am. J. Physiol., 213: 915.
Salzman, E.W., Rosenberg, R.D., Smith, M.H., Lindon, J.N. and Favreau, L., 1980. Effect of heparin and heparin fractions on platelet aggregation. J. Clin. Invest., 65: 64.
Saphir, J.R. and Ney, R.G., 1966. Delayed thrombocytopenic purpura after diminutive gold therapy. J. Am. Med. Assn., 195: 782.
Schalm, O.W., 1971. The blood platelets (Thombocytes). II. The thrombocytopathies. Calif. Vet., 25: 6.
Sheiman, L., Spielvogel, A.R. and Horowitz, H.I., 1968. Thrombocytopenia caused by cephalothin sodium: Occurrence in a penicillin sensitive individual. J. Am. Med. Assn., 203: 159.
Shulman, N.R., 1958. Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelet; and for fixation of complement by the complex. J. Exp. Med., 107: 665.
Shulman, N.R., 1964. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in auto-imminity. Ann. Intern. Med., 50: 506.
Shulman, N.R. and Jordan, J.V. Jr., 1982. Platelet immunology. In: R.W. Colman, J. Hirsh, V.J. Marder and E.W. Salzman (Editors), Hemostasis and Thrombosis, J.B. Lippincott Company, Philadelphia, pp. 274–342.
Stavem, P., Stromme, J. and Bull, O., 1968. Immunological studies in a case of gold salt-induced thrombocytopenia. Scand. J. Haematol., 5: 271.
Stefanini, M. and Hoffman, M.N., 1978. Studies on platelets: XXVIII: Acute thrombocytopenic purpura due to lidocaine (xylocaine) mediated antibody. Report of a case. Am. J. Med. Sci., 275: 365.
Steinberg, S., 1970. Aplastic anemia in a dog. J. Am. Med. Assn., 157: 966.
Teske, E. and Feldman, B.F., 1984. Hypoplasia of bone marrow following oestrogen therapy. Tijdshr. Diergeneeskd., 109: 357.
Trono, D.P., Kaelin, R.M., Thonney, J.L. and Vader, J.P., 1984. Thrombocytopenia and heparin associated thrombosis. Ann. Intern. Med., 100: 464.
Tyslowitz, R. and Dingemanse, E., 1941. Effects of large doses of estrogens on the blood picture of dogs. Endocrinol., 29: 817.
Tyslowitz, R. and Hartman, C.G., 1941. Influence of large doses of estrogens on the blood picture of Rhesus monkeys (Macaca mulatta). Endocrinol., 29: 349.
Wanamaker, W.M., Wanamaker, S.J., Celesia, G.G. and Koeller, A.A., 1976. Thrombocytopenia associated with long term levodopa therapy. J. Am. Med. Assn., 235: 2217.
Watson, C.J., Schultz, A.L. and Wikoff, H.M., 1947. Purpura following estrogen therapy with particular reference to hypersensitivity to (diethyl) stilbestrol and with a note on the possible relationship to purpura to endogenous estrogens. J. Lab. Clin. Med., 32: 606.
Weisfuse, L., Spear, P.W. and Sass, M., 1954. Quinidine-induced thrombocytopenic purpura. Am. J. Med., 17: 414.
Weismann, R.E. and Tobin, R.W., 1958. Arterial embolism occurring during systemic heparin therapy. A.M.A. Arch. Surg., 76: 219.
White, P.W., Sadd, J.R. and Nensel, R.E., 1979. Thrombotic complications of heparin therapy including six cases of heparin-induced skin necrosis. Ann. Surg., 190: 595.
Worlledge, S.M., 1969. Autoantibody formation associated with methyldopa (Aldomet) therapy. Br. J. Haematol., 16: 5.
Worlledge, S.M., 1973. Immune drug-induced hemolytic anemias. Semin. Hematol., 4: 327.
Worlledge, S.M., Carstairs, K.C. and Dacie, J.V., 1966. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet. 2: 135.
Young, R.C., Nachman, R.L. and Horowitz, H.I., 1966. Thrombocytopenia due to digoxin. Demonstration of antibody and mechanism of action. Am. J. Med., 41: 605.
Yu-Jen, H., Hu-Ying, K. and An, O., 1966. Thrombocytopenia following administration of penicillin: Report of a case. Chinese Med. J., 85: 249.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Handagama, P.J., Feldman, B.F. Drug-induced thrombocytopenia. Vet Res Commun 10, 1–20 (1986). https://doi.org/10.1007/BF02213961
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02213961